Saptarshi Sinha
6PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 31, 2024
Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells.Somya Ranjan Dash, Chinmay Das, Biswajit Das
|Jan 06, 2024
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation.Saptarshi Sinha, Subarno Paul, Sushree Subhadra Acharya
|Mar 14, 2023
Near-infrared enhances antiangiogenic potentiality of quinacrine-gold hybrid nanoparticles in breast cancer stem cells via deregulation of HSP-70/TGF-β.Somya Ranjan Dash, Biswajit Das, Chinmay Das
|Aug 25, 2021
PARP1-modulated chromatin remodeling is a new target for cancer treatment.Saptarshi Sinha, Sefinew Molla, Chanakya Nath Kundu
|Jul 24, 2021
Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?Saptarshi Sinha, Chanakya Nath Kundu
|Oct 13, 2018
Synthesis and Microtubule-Destabilizing Activity of N-Cyclopropyl-4-((3,4-dihydroquinolin-1(2H)-yl)sulfonyl)benzamide and its Analogs.Jessica J Field, A Jonathan Singh, Saptarshi Sinha
Pageof 1
Frequent Collaborators
5 joint publications
Chanakya Nath Kundu
3 joint publications
Subarno Paul
3 joint publications
Somya Ranjan Dash
3 joint publications
Biswajit Das
3 joint publications
Chinmay Das
2 joint publications
Rajalaxmi Pradhan
1 joint publications
Jessica J Field
1 joint publications
A Jonathan Singh
1 joint publications
Matthew R Rowe
1 joint publications
Atala Bihari Jena
